Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Elliott Grossbard, M.D.
Rigel Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Aranda de la Parra
León, GT, Mexico
- Hospital Civil de Guadalajara "dr. Juan I. Menchaca"
Guadalajara, JA, Mexico
- Hospital Civil de Guadalajara "fray Antonio Alcalde"
Guadalajara, JA, Mexico
- Centro Médico del Instituto de Seguridad Social del Estado de Mexico Y Municipios (cmissemym)
Metepec, MX, Mexico
- Arke Estudios Clinicos, S.A. de C.V.
Mexico City, Mexico City, Mexico
- Centro Médico Dalinde
Mexico City, Mexico City, Mexico
- Clinica Para El Diagnostico Y Tratamiento de Las Enfermedades Reumaticas, S.C.
Mexico City, Mexico City, Mexico
- Hospital General de Mexico
Mexico City, Mexico City, Mexico
- Hospital Regional "1° de Octubre", Issste
Mexico City, Mexico City, Mexico
- Facultad de Medicina Y Hospital Universitario "dr. Jose E. Gonzalez" de la Universidad Autonoma de Nuevo Leon
Monterrey, Nuevo León, Mexico
- Hospital Central "dr. Ignacio Morones Prieto"
San Luis Potosí City, SL, Mexico
- Pacific Arthritis Center Medical Group
Santa Maria, California, United States
- Dmi Research
Ocala, Florida, United States
- Renstar Medical Research
Ocala, Florida, United States
- Arthritis & Osteoporosis Treatment Center
Orange Park, Florida, United States
- Arthritis Associates Inc.
Orlando, Florida, United States
- Arthritis Research of Florida
Palm Harbor, Florida, United States
- Arthritis Research of Florida, Inc.
Palm Harbor, Florida, United States
- Lovelace Scientific Resources
Sarasota, Florida, United States
- the Center for Arthritis and Rheumatic Diseas
South Miami, Florida, United States
- Coeur D'Alene Arthritis Clinical Trials
Coeur d'Alene, Idaho, United States
- the Arthritis Center
Springfield, Illinois, United States
- Mmg Clinical Research
South Bend, Indiana, United States
- Phase Iii Clinical Research
Fall River, Massachusetts, United States
- Michigan Arthritis Research Center
Brighton, Michigan, United States
- Westroad Medical Group
Omaha, Nebraska, United States
- Nc Arthritis & Allergy Care Center
Raleigh, North Carolina, United States
- Clinical Research Division
Mayfield Village, Ohio, United States
- Lynn Health Science Institute
Oklahoma City, Oklahoma, United States
- East Penn Rheumatology Associates
Bethlehem, Pennsylvania, United States
- Altoona Ctr. for Clinical Research
Duncansville, Pennsylvania, United States
- Clinical Research Center of Reading Llp
West Reading, Pennsylvania, United States
- Low Country Rheumatology
Charleston, South Carolina, United States
- Arthritis Clinic
Jackson, Tennessee, United States
- Scri
Memphis, Tennessee, United States
- Austin Rheumatology Research
Austin, Texas, United States
- Research Across America
El Paso, Texas, United States
- Center for Arth. & Rheum. Disease, Pc
Chesapeake, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2006
- Primary completion
- 31 Oct 2007
- Completion
- 31 Dec 2007
- Last update posted
- 20 Apr 2009
- Registered enrollment
- 189
- Registry id
- NCT00326339
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.